We at Magellan Biologics & Consulting are proud of this great achievement for our sister Company ExcellGene SA and congratulate, together with the whole ExcellGene team, all the consortium members: Bharat Biotech International Limited and the University of Sydney on their commitment to the progress of science and medicine! This new milestone for CEPI (Coalition for Epidemic Preparedness Innovations) is of paramount importance in our global effort towards the objective of a long-term control of the #sarscov2 virus.
New Peer-Reviewed Paper in Antibodies Highlights Pfizer’s Outstanding Results with CHO 4Tx®
At the heart of this publication, entitled “A Robust, High-Titer, Semi-Automated, and In-Culture Antibody-Capturing Transient CHO Platform Technology” and co-authored by Pfizer, Magellan Biologics, and
7 November 2025
